Table 3.
No. of studies | RR (95% CI) | Heterogeneity p | p | ||
---|---|---|---|---|---|
Serum UA level | |||||
1 | Age (mean/median) | ||||
>50 | 19 | 1.26 (1.17–1.35) | 0.001 | <0.001 | |
≤50 | 8 | 1.12 (1.06–1.18) | 0.7 | <0.001 | |
2 | Percentage of women | ||||
>45 | 16 | 1.24 (1.14–1.34) | 0.001 | <0.001 | |
≤45 | 11 | 1.20 (1.08–1.34) | 0.006 | 0.001 | |
3 | No. of participants | ||||
>15,000 | 9 | 1.21 (1.11–1.32) | 0.001 | <0.001 | |
≤15,000 | 18 | 1.23 (1.14–1.34) | 0.2 | <0.001 | |
4 | No. of cases | ||||
>500 | 8 | 1.21 (1.11–1.33) | 0.001 | <0.001 | |
≤500 | 19 | 1.22 (1.13–1.32) | 0.3 | <0.001 | |
5 | Location | ||||
United States | 2 | 1.23 (0.88–1.71) | 0.2 | 0.226 | |
Europe | 12 | 1.20 (1.11–1.29) | 0.001 | <0.001 | |
Aisa | 13 | 1.28 (1.16–1.41) | 0.4 | <0.001 | |
6 | Follow-up time | ||||
>10 | 15 | 1.20 (1.12–1.29) | 0.001 | <0.001 | |
≤10 | 12 | 1.29 (1.14–1.44) | 0.3 | <0.001 | |
7 | Quality | ||||
>7 | 20 | 1.22 (1.14–1.30) | 0.001 | <0.001 | |
≤7 | 7 | 1.26 (1.08–1.47) | 0.1 | 0.003 | |
8 | Adjusted | ||||
Yes | 25 | 1.22 (1.15–1.30) | 0.001 | <0.001 | |
No | 2 | 1.08 (0.61–1.91) | 0.9 | 0.791 | |
9 | Subtype of stroke | ||||
Ischemic stroke | 16 | 1.34 (1.24–1.45) | 0.2 | <0.001 | |
Hemorrhagic stroke | 9 | 1.41 (1.12–1.77) | 0.01 | 0.004 | |
10 | Sex | ||||
Male | 13 | 1.20 (1.12–1.29) | 0.001 | <0.001 | |
Female | 11 | 1.27 (1.30–1.47) | 0.001 | <0.001 |